Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

ClinicalTrials.gov ID: NCT03738215

Public ClinicalTrials.gov record NCT03738215. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 1:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled Study of Cariprazine as an Adjunct to Antidepressants in the Treatment of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to Antidepressants Alone

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to evaluate the efficacy, safety and tolerability of cariprazine as an adjunctive treatment to antidepressant therapy (ADT) in patients with MDD who have had an inadequate response to antidepressants alone.

Study identification

NCT ID
NCT03738215
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
759 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 9, 2018 (Actual)
Primary completion
Sep 30, 2021 (Actual)
Completion
Sep 30, 2021 (Actual)
Last update posted
Oct 25, 2022

2018 – 2021

United States locations

U.S. sites
65
U.S. states
25
U.S. cities
62
Facility City State ZIP Site status
Alea Research /ID# 234789 Phoenix Arizona 85012-2707 —
Atria Clinical Research /ID# 237988 Little Rock Arkansas 72209-7040 —
Woodland Research Northwest, LLC /ID# 236641 Rogers Arkansas 72758-6442 —
California Pharmaceutical Research Institute /ID# 236732 Anaheim California 92804-3738 —
Advanced Research Center /ID# 237957 Anaheim California 92805 —
Axiom Research /ID# 236268 Colton California 92324 —
ATP Clinical Research, Inc /ID# 236619 Costa Mesa California 92626-4607 —
ProScience Research Group /ID# 236442 Culver City California 90230-6632 —
Collaborative Neuroscience Research - Orange County /ID# 237639 Garden Grove California 92845 —
Irvine Clinical Research /ID# 237409 Irvine California 92614 —
Omega Clinical Trials LLC /ID# 238168 La Habra California 90631-3842 —
Synergy San Diego /ID# 236654 Lemon Grove California 91945-2956 —
Anderson Clinical Research /ID# 236627 Redlands California 92374-4555 —
Sharp Mesa Vista Hospital /ID# 235797 San Diego California 92123 —
Viking Clinical Research /ID# 236614 Temecula California 92591-6200 —
Olympian Clinical Research /ID# 237417 Clearwater Florida 33756 —
MD Clinical Hallandale Florida 33009 —
Reliable Clinical Research /ID# 234786 Hialeah Florida 33012-5830 —
CNS Healthcare - Jacksonville /ID# 238241 Jacksonville Florida 32256-6039 —
Space Coast Neuropsychiatric Research Institute /ID# 235765 Palm Bay Florida 32905 —
University of South Florida /ID# 234386 Tampa Florida 33606 —
Institute for Advanced Medical Research /ID# 236672 Alpharetta Georgia 30022-1142 —
iResearch Atlanta, LLC /ID# 237389 Decatur Georgia 30030 —
Psych Atlanta /ID# 235835 Marietta Georgia 30060 —
Capstone Clinical Research /ID# 236546 Libertyville Illinois 60048-5341 —
Pillar Clinical Research /ID# 235702 Lincolnwood Illinois 60712 —
NeuroPsychiatric Research Practice & Associate LTD /ID# 234636 Winfield Illinois 60190 —
Lake Charles Clinical Trials /ID# 237723 Lake Charles Louisiana 70629 —
J. Gary Booker MD APMC /ID# 234514 Shreveport Louisiana 71104 —
Pharmasite Research, Inc. /ID# 237395 Baltimore Maryland 21208 —
CBH Health LLC /ID# 234536 Gaithersburg Maryland 20877 —
Michigan Clinical Research Institute /ID# 234792 Ann Arbor Michigan 48105-3205 —
NeuroBehavioral Medicine Group /ID# 236671 Bloomfield Hills Michigan 48302 —
Precise Research Centers /ID# 236598 Flowood Mississippi 39232-8839 —
Millennium Psychiatric Associates LLC /ID# 235989 St Louis Missouri 63132 —
Alivation Research /ID# 236583 Lincoln Nebraska 68526-9474 —
Altea Research Institute /ID# 236726 Las Vegas Nevada 89102-1955 —
Hassman Research Institute /ID# 237501 Berlin New Jersey 08009 —
Integrative Clinical Trials /ID# 236656 Brooklyn New York 11229-3576 —
Manhattan Behavioral Medicine PLLC /ID# 236314 New York New York 10036 —
Finger Lakes Clinical Research /ID# 236578 Rochester New York 14618-1609 —
New Hope Clinical Research Inc. /ID# 234557 Charlotte North Carolina 28211 —
Richard Weisler MD, PA & Assoc /ID# 237424 Raleigh North Carolina 27609 —
Quest Therapeutics of Avon Lake /ID# 236282 Avon Lake Ohio 44012 —
CTI Clinical Trial and Consulting /ID# 236271 Cincinnati Ohio 45212 —
The Ohio State University Department of Psychiatry /ID# 234583 Columbus Ohio 43210 —
CincyScience /ID# 236391 West Chester Ohio 45069 —
IPS Research Company /ID# 237671 Oklahoma City Oklahoma 73106 —
Sooner Clinical Research /ID# 236346 Oklahoma City Oklahoma 73112 —
Oregon Center for Clinical Investigations, Inc. - Portland /ID# 236649 Portland Oregon 97214-2569 —
Lehigh Center for Clinical Research /ID# 236702 Allentown Pennsylvania 18104-5034 —
Coastal Carolina Research Center /ID# 235909 North Charleston South Carolina 29405 —
Psychiatric Consultants PC /ID# 235839 Franklin Tennessee 37067 —
Clinical Neuroscience Solutions - Memphis /ID# 237476 Memphis Tennessee 38119 —
Austin Clinical Trial Partners /ID# 236551 Austin Texas 78737 —
BioBehavioral Research of Austin /ID# 236477 Austin Texas 78759-5290 —
Houston Clinical Trials /ID# 234442 Bellaire Texas 77401-2928 —
FutureSearch Trials of Dallas, LP /ID# 236275 Dallas Texas 75231 —
Earle Research /ID# 236661 Friendswood Texas 77546 —
Red Oak Psychiatry Associates /ID# 236600 Houston Texas 77090-2641 —
AIM Trials /ID# 236369 Plano Texas 75093 —
Pillar Clinical Research LLC /ID# 234465 Richardson Texas 75080 —
Neuropsychiatric Associates LLC/DBA Woodstock Research Center /ID# 236087 Woodstock Vermont 05091 —
Northwest Clinical Research Center /ID# 237584 Bellevue Washington 98007 —
Core Clinical Research /ID# 236405 Everett Washington 98201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03738215, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 25, 2022 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03738215 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →